Apr 9, 2026 08:03AM Zentalis selects 400mg dose for azenosertib ovarian cancer trials

Mar 27, 2026 12:16PM TD Cowen: Accumulate Zentalis (ZNTL) shares here

Mar 27, 2026 06:07AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)

Mar 27, 2026 06:02AM Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

Mar 17, 2026 06:10AM Wells Fargo Assumes Zentalis Pharmaceuticals (ZNTL) at Equal Weight

Jan 6, 2026 08:12AM Zentalis advances azenosertib toward potential ovarian cancer approval in 2026

Nov 11, 2025 04:50AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2 at Leerink Partners

Nov 10, 2025 04:07PM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 16c

Oct 13, 2025 04:07PM Zentalis to present four azenosertib studies at cancer conference

Aug 6, 2025 06:10PM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q2 EPS by 17c

Jun 2, 2025 06:56AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)

May 14, 2025 04:22PM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q1 EPS by 1c

Mar 27, 2025 07:54AM Stifel Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)

Mar 27, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)

Mar 26, 2025 04:20PM Zentalis Pharmaceuticals (ZNTL) Files $250M Mixed Shelf

Mar 17, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)

Jan 30, 2025 06:40AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at H.C. Wainwright

Jan 29, 2025 01:58PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2.50 at Jefferies

Jan 29, 2025 10:18AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at Oppenheimer

Jan 29, 2025 07:09AM Zentalis Pharmaceuticals (ZNTL) Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

Jan 28, 2025 04:07PM Zentalis Pharmaceuticals (ZNTL) Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

Dec 12, 2024 07:04AM Zentalis Pharmaceuticals (ZNTL) Announces Management Appointments

Nov 13, 2024 08:01AM Zentalis Pharmaceuticals (ZNTL) Announces Executive Leadership Changes

Sep 16, 2024 12:18PM TD Cowen Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)

Sep 16, 2024 11:55AM Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

Sep 16, 2024 07:01AM Zentalis Pharmaceuticals (ZNTL) Announces FDA Lifted Partial Clinical Hold on Azenosertib Studies

Jun 20, 2024 06:10AM UBS Downgrades Zentalis Pharmaceuticals (ZNTL) to Neutral

Jun 18, 2024 02:19PM Jefferies Downgrades Zentalis Pharmaceuticals (ZNTL) to Hold

Jun 18, 2024 01:32PM Morgan Stanley Downgrades Zentalis Pharmaceuticals (ZNTL) to Equalweight

Jun 18, 2024 12:13PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $20 at H.C. Wainwright

Jun 18, 2024 11:17AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at Stifel

Jun 18, 2024 09:31AM Wells Fargo Downgrades Zentalis Pharmaceuticals (ZNTL) to Equal Weight

Jun 18, 2024 07:32AM Zentalis Pharmaceuticals (ZNTL) Resumes Trading, Down 29%

Jun 18, 2024 07:00AM Zentalis Pharmaceuticals (ZNTL) Provides Update on Azenosertib Clinical Development Program